Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Reductive Deuteration. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel SmI2-catalyzed reductive deuteration of nitriles offers high yield and regioselectivity. A cost-effective supply chain solution for deuterated drug manufacturing.
Patent CN112430187A reveals a novel SmI2-catalyzed reductive deuteration method for high-purity pharmaceutical intermediates, offering significant cost and supply chain advantages.